A Career That Changes Lives

The Minneapolis Heart Institute Foundation strives to create a world without heart and vascular disease. As a member of the team, you will have opportunities to make a difference every day by enabling cardiovascular research and education that changes patient lives.

mhif staff holding hearts

Why Join MHIF

MHIF is a leading global nonprofit cardiovascular research institution with over 230 research studies and publications releasing each year. At the heart of this work is our passionate and skilled team of 100+ professionals who keep our 40+ year-old mission moving forward.

Joining the MHIF team means building a career that changes lives. We work closely with world-renowned physicians from Allina Health Minneapolis Heart Institute® to build cutting-edge research. Our trusted relationships with clinicians and patients give us the necessary tools for new discoveries and advancements in cardiovascular care.

Central to the MHIF culture are our values of Integrity, Excellence, Innovation and Collaboration that guide our actions, behaviors and decision-making. These values are reflective of the type of work and Top Workplace we strive to be.


Total Rewards

We provide comprehensive employee benefits and an award-winning work environment:

Give the Gift of Hope
4 photos of families smiling

The Minneapolis Heart Institute Foundation® (MHIF) strives to create a world without heart and vascular disease. To achieve this bold vision, we are dedicated to improving the cardiovascular health of individuals and communities through innovative research and education.

Thanks to the generosity of donors like you, we can continue this life-saving work. Please make a gift to support the area of greatest need.

Research Milestone: FDA approval of the TriClip™

blue background

A new treatment for leaky tricuspid valves has been approved by the FDA. This new therapy is available for patients living with the debilitating effects of tricuspid regurgitation. We were proud to be a leading clinical site led by Global PI Dr. Paul Sorajja and the MHIF research team who contributed significant data to the pivotal trial – and going back to the first patient to have access to this technology through research.